Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Pharmnovo Aktiebolag
AB
Active
Org 5567397368
Scheeletorget 1, 223 81
Lund
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2007
1-4 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Pharmnovo Aktiebolag
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (2)
PM
Per Mikael von Mentzer
Chief Executive Officer
Chief Executive Officer
2021
OS
Olof Sören Maxén
Audit
Audit
2020
Former (1)
BA
Bengt Anders von Mentzer
Chief Executive Officer
Chief Executive Officer
2020 – 2021
Board of directors
Non-executive oversight
Name
Role
Member since
Current (6)
DA
David Allan Kendall
Board of Directors
2020
JL
Johan Lars Fredrik Lund
Chairman
2026
JU
Johan Ulf Niclas Dighed
Board of Directors
2025
HM
Helen Monika Pettersson
Board of Directors
2022
AP
Anthony Paul David Webber Ford
Board of Directors
2020
KE
Karin Elisabeth Rosén
Board of Directors
2026
Former (4)
PG
Per Gunnar Ernst Aniansson
Board of Directors
2022 – 2025
LS
Linda Spahiu Elvesjö
Deputy Board Member
2022 – 2025
HG
Hans Gunnar Nilsson
Board of Directors
2020 – 2022
PG
Per Göran Lerenius
Chairman
2020 – 2026
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Pharmnovo Aktiebolag
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network